About the Cashmere Collection

 The world’s first and only fashion collection crafted in luxuriously soft Cashmere Bathroom Tissue (BT), the annual Cashmere Collection™ unites the softness of Cashmere Bathroom Tissue with Canadian fashion designers and their one-of-a-kind Bathroom Tissue Fashion. Now celebrating its 15th year as a national and international platform to discover and promote Canada’s brightest fashion stars, the Cashmere Collection has featured many notable Canadian fashion designers to date, including Marie Saint Pierre, Denis Gagnon, David Dixon, Sunny Fong, UNTTLD, Stephan Caras, Joseph Helmer, and Lesley Hampton.

The annual kick-off to October Breast Cancer Awareness Month, The Cashmere Collection heralds the return of limited-edition Cashmere in support of breast cancer efforts. Twenty-five cents from the sale of every specially marked package goes directly to the cause throughout the month.

Cashmere Ultra 3.png

About Cashmere and Kruger Products L.P.

Cashmere, Canada’s best-selling bathroom tissue, reflects Kruger Products’ commitment to providing the finest quality tissue products to Canadian consumers. Kruger Products is one of Canada’s leading tissue manufacturers and serves the Canadian consumer market with well-known brands such as Cashmere, Purex, SpongeTowels and Scotties, as well as away-from-home products for industrial and commercial use across Canada and the U.S.

A longstanding and committed contributor to the breast cancer cause, Kruger Products L.P. has supported the Canadian Breast Cancer Foundation (CBCF), now known as the Canadian Cancer Society (CCS) since the collection’s debut in 2004, and today is one of the top 5 partners supporting the breast cancer cause at CCS.

About Breast Cancer and the Canadian Cancer Society

It was estimated in 2017 that 26,300 Canadian women were diagnosed with breast cancer and on average, 14 Canadian women died from the disease each day. The Canadian Cancer Society (CCS) is a national, community-based organization of volunteers whose mission is to eradicate cancer and enhance the quality of life of people living with cancer.

CCS has invested more than $100 million in breast cancer research. These research investments combined with early detection, increased screening rates and better treatment therapies for breast cancer have resulted in a 44% decrease in the breast cancer death rate since the late 1980s. More work needs to be done as breast cancer is still the most commonly diagnosed cancer and the second leading cause of death among women in Canada. Money raised through this partnership will fund breast cancer research, education and awareness activities. For more information, please visit cancer.ca/breastcancer.